These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 36851320)

  • 1. A Case Series and Literature Review of Telogen Effluvium and Alopecia Universalis after the Administration of a Heterologous COVID-19 Vaccine Scheme.
    Hernández Arroyo J; Izquierdo-Condoy JS; Ortiz-Prado E
    Vaccines (Basel); 2023 Feb; 11(2):. PubMed ID: 36851320
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of SARS-CoV-2 infection and its vaccines in various types of hair loss.
    Aryanian Z; Balighi K; Hatami P; Afshar ZM; Mohandesi NA
    Dermatol Ther; 2022 Jun; 35(6):e15433. PubMed ID: 35266262
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Alopecia Areata after COVID-19 Vaccines.
    Genco L; Cantelli M; Noto M; Battista T; Patrì A; Fabbrocini G; Vastarella M
    Skin Appendage Disord; 2023 Mar; 9(2):141-143. PubMed ID: 36926281
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Not just thinning: A case of alopecia universalis after mild COVID-19.
    Phong CH; Babadjouni A; Nguyen C; Kraus CN; Mesinkovska NA
    JAAD Case Rep; 2022 Jul; 25():1-3. PubMed ID: 35571455
    [No Abstract]   [Full Text] [Related]  

  • 5. COVID-19 infection is a major cause of acute telogen effluvium.
    Sharquie KE; Jabbar RI
    Ir J Med Sci; 2022 Aug; 191(4):1677-1681. PubMed ID: 34467470
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Telogen effluvium after COVID-19 vaccination among public in Saudi Arabia.
    Alharbi M
    J Family Med Prim Care; 2022 Oct; 11(10):6056-6060. PubMed ID: 36618187
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of patients with telogen effluvium during the pandemic: May the monocytes be responsible for post COVID-19 telogen effluvium?
    Koç Yıldırım S; Erbağcı E; Demirel Öğüt N
    J Cosmet Dermatol; 2022 May; 21(5):1809-1815. PubMed ID: 35201647
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characteristics of telogen effluvium in COVID-19 in western Iran (2020).
    Babaei K; Kavoussi H; Rezaei M; Kavoussi R
    An Bras Dermatol; 2021; 96(6):688-692. PubMed ID: 34593265
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Telogen effluvium related to post severe Sars-Cov-2 infection: Clinical aspects and our management experience.
    Rizzetto G; Diotallevi F; Campanati A; Radi G; Bianchelli T; Molinelli E; Mazzanti S; Offidani A
    Dermatol Ther; 2021 Jan; 34(1):e14547. PubMed ID: 33190397
    [TBL] [Abstract][Full Text] [Related]  

  • 10. COVID-19 induced telogen effluvium.
    Aksoy H; Yıldırım UM; Ergen P; Gürel MS
    Dermatol Ther; 2021 Nov; 34(6):e15175. PubMed ID: 34708909
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy of QR678 Neo
    Shome D; Kapoor R; Surana M; Vadera S; Shah R
    J Cosmet Dermatol; 2022 Jan; 21(1):16-23. PubMed ID: 34875139
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sequential cyclic changes of hair roots revealed by dermoscopy demonstrate a progressive mechanism of diffuse alopecia areata over time.
    Zhang X; Ye Y; Zhu Z; Yang Y; Cao H; McElwee KJ; Ling Y
    Exp Dermatol; 2020 Mar; 29(3):223-230. PubMed ID: 30307062
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acute telogen effluvium triad after resolution.
    Contin LA; Rocha VB
    An Bras Dermatol; 2021; 96(5):605-608. PubMed ID: 34272075
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Telogen effluvium following bivalent human papillomavirus vaccine administration: a report of two cases.
    Tuccori M; Pisani C; Bachini L; Pardini M; Mantarro S; Antonioli L; Fornai M; Rubinelli M; Cirinei C; Blandizzi C
    Dermatology; 2012; 224(3):212-4. PubMed ID: 22584489
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevalence of telogen effluvium hair loss in COVID-19 patients and its relationship with disease severity.
    Seyfi S; Alijanpour R; Aryanian Z; Ezoji K; Mahmoudi M
    J Med Life; 2022 May; 15(5):631-634. PubMed ID: 35815081
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Alopecia in patients with COVID-19: A systematic review and meta-analysis.
    Nguyen B; Tosti A
    JAAD Int; 2022 Jun; 7():67-77. PubMed ID: 35224518
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Post-COVID Telogen Effluvium.
    Tešanović Perković D; Vukojević M; Bukvić Mokos Z
    Acta Dermatovenerol Croat; 2022 Dec; 30(4):220-226. PubMed ID: 36919388
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oral minoxidil use in androgenetic alopecia and telogen effluvium.
    Feaster B; Onamusi T; Cooley JE; McMichael AJ
    Arch Dermatol Res; 2023 Mar; 315(2):201-205. PubMed ID: 35244759
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Platelet-Rich Plasma Treatment for Accelerated Androgenetic Alopecia Pattern Hair Loss After COVID-19 Infection: A Case Series.
    İşlek A; Karaaslan E; Şimşek S; Merve Çetin F
    J Cosmet Dermatol; 2022 Feb; 21(2):590-594. PubMed ID: 34965004
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Post-SARS-CoV-2 Acute Telogen Effluvium: An Expected Complication.
    Monari P; Gualdi G; Bettoni G; Costa R; Ragni G; Zani F; Bianchi G; Casella S; Casella E; Crippa M; Calzavara Pinton P; Di Nicola M; Porreca A; Amerio P; Guizzi P
    J Clin Med; 2022 Feb; 11(5):. PubMed ID: 35268325
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.